<?xml version="1.0" encoding="UTF-8"?>
<ref id="B137-antioxidants-09-01191">
 <label>137.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Fu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X.</given-names>
   </name>
  </person-group>
  <article-title>Targeting HO-1 by epigallocatechin-3-gallate reduces contrast-induced renal injury via anti-oxidative stress and anti-inflammation pathways</article-title>
  <source>PLoS ONE</source>
  <year>2016</year>
  <volume>11</volume>
  <elocation-id>e0149032</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0149032</pub-id>
  <pub-id pub-id-type="pmid">26866373</pub-id>
 </element-citation>
</ref>
